Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Dustan

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Virological Methods|May 26, 2004
Detection of HIV-1 antiretroviral resistance from patients with persistently low but detectable viraemiaNicola Mackie, Simon Dustan, Myra O McClure, et al.
Plos One|August 31, 2011
DNA extraction columns contaminated with murine sequencesOtto Erlwein, Mark J Robinson, Simon Dustan, et al.
AIDS (London, England)|January 2, 2007
Prevalence of primary genotypic resistance in a UK centre: Comparison of primary HIV-1 and newly diagnosed treatment-naive individualsJulie Fox, Samantha Hill, Steve Kaye, et al.
AIDS (London, England)|December 6, 2024
Proviral HIV DNA sequencing to inform suitability for long-acting injectable cabotegravir/rilpivirineJasmini Alagaratnam, Niall Kelly, Simon Dustan, et al.
The Journal of Infection|February 5, 2020
Comparative hepatitis C genotype 1-3 viral load kinetics in response to directly-acting antiviral therapyShoshanna May, Feza Kurmoo, Mariesa Iliffe, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Virological Methods|May 26, 2004
Detection of HIV-1 antiretroviral resistance from patients with persistently low but detectable viraemiaNicola Mackie, Simon Dustan, Myra O McClure, et al.
Plos One|August 31, 2011
DNA extraction columns contaminated with murine sequencesOtto Erlwein, Mark J Robinson, Simon Dustan, et al.
AIDS (London, England)|January 2, 2007
Prevalence of primary genotypic resistance in a UK centre: Comparison of primary HIV-1 and newly diagnosed treatment-naive individualsJulie Fox, Samantha Hill, Steve Kaye, et al.
AIDS (London, England)|December 6, 2024
Proviral HIV DNA sequencing to inform suitability for long-acting injectable cabotegravir/rilpivirineJasmini Alagaratnam, Niall Kelly, Simon Dustan, et al.
The Journal of Infection|February 5, 2020
Comparative hepatitis C genotype 1-3 viral load kinetics in response to directly-acting antiviral therapyShoshanna May, Feza Kurmoo, Mariesa Iliffe, et al.
Pageof 1